A Study of the Safety, Tolerability, and Pharmacokinetics of NYR-BI03 in Healthy Participants
Clinical trial NCT06894862 · COMPLETED
Trial details
- NCT number
- NCT06894862
- Sponsor
- Nyrada Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-19
- Primary completion
- 2025-07-24
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.